Clinical features and prognostic factors of early breast cancer at a major cancer center in North India

Indian Journal of Cancer

Volumn 42, Issue 1, 2005, Pages 36-41

  Raina, Vinod ^a   Bhutani, Manisha ^a   Bedi, Rajeev ^a   Sharma, Atul ^a   Deo, Suryanarayana V S ^a   Shukla, Nootan K ^a   Mohanti, Bidhu Kalyan ^a   Rath, Goura K ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Breast cancer; Epidemiology; India; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INDIA; MEDICAL RECORD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; TUMOR RECURRENCE;

NEOPLASMS, HORMONE-DEPENDENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INDIA; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 22244450989     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-509x.15099     Document Type: Article

References (25)

1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. Version 2.0, IARC Press, Lyon, 2004. Available from: http://www-dep.iarc.fr/.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
3. Goel AK, Seenu V, Shukla NK, Raina V. Breast cancer presentation at a regional cancer center. Natl Med J India 1995;8:6-9.
4. Gajalakshmi CK, Shanta V, Swaminathan R, Sankaranarayanan R, Black RJ. A population-based survival study on female breast cancer in Madras, India. Br J Cancer 1997;75:771-5.
5. Nandakumar A, Anantha N, Venugopal TC, Sankaranarayanan R, Thimmasetty K, Dhar M. Survival in breast cancer: A population-based study in Bangalore, India. Int J Cancer 1995;60:593-6.
6. Sobin LH, Wittekind Ch., editors. UICC TNM Classification of malignant tumors. 5th Ed. New York: John Wiley & Sons, Inc.; 1997.
7. National Cancer Registry Programme. Ten year consolidated report of the hospital based cancer registries 1984-1993. An assessment of the burden and care of cancer patients. New Delhi: Indian Council of Medical Research; 2001.
8. National Cancer Registry Programme. Consolidated report of the population based cancer registries1990-1996. New Delhi: Indian Council of Medical Research; 2001.
9. National Cancer Registry Programme. Consolidated report of the population based cancer registries1990-1996. Supplement: Year-wise tabulation of incident cancers and rates by site and gender. New Delhi: Indian Council of Medical Research; 2001.
10. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer 2002;100:86-91.
11. Parkin DM, Whelan SL, Ferlay J, Raymond, L, Young J, editors. Cancer Incidence in Five Continents. Vol VII. IARC Scientific Publication 143. Lyon: International Agency for Research on Cancer; 1997.
12. Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic malignancies in India. Med Oncol 2002;19:141-50.
13. Pegoraro RJ, Nirmul D, Bryer JV, Jordaan JP, Joubert SM. Clinical patterns of presentation of breast cancer of different racial groups in South Africa. S Afr Med J 1985;68:808-10.
14. Kemperman H, Borger J, Hart A, Peterse H, Bartelink H, van Dongen J. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence. Eur J Cancer 1995;31A:690-8.
15. Mansfield CM, Komarnicky LT, Schwartz GF, Rosenberg AL, Krishnan L, Jewell WR, et al. Cancer 1995;75:2328-36.
16. Jacobson JA, Danforth DN, Cowan KH, d'Angelo T, Steinberg SM, Pierce L, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995;332:907-11.
17. Bland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-73.
18. NHS Breast Screening Programme and British Association of Surgical Oncology. Audit of screen detected breast cancers 1997-1998. NHS Breast Screening Programme, 1999.
19. Deo SS, Mohanti BK, Shukla NK, Chawla S, Raina V, Julka PK, et al. Attitudes and treatment outcome of breast conservation therapy for stage I and II breast cancer using peroperative iridium-192 implant boost to the tumour bed. Australas Radiol 2001;45:35-8.
20. Raina V, Taneja V, Gulati A, Deo SVS, Shukla NK, Vij U, et al. Oestrogen receptor status in breast cancer. Indian Pract 2000;53:405-7.
21. Redkar AA, Kabre SS, Mittra I. Estrogen and progesterone receptors measurement in breast cancer with enzyme-immunoassay and correlation with other prognostic factors. Indian J Med Res 1992;96:1-8.
22. Biesterfeld S, Schroder W, Steinhagen G, Koch R, Veuskens U, Schmitz FJ, et al. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information. Anticancer Res 1997;17:4723-9.
23. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003;21:28-34.
24. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992;28A:801-5.
25. Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Zambetti M, et al. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 1985;5:95-115.